In the PCOS mouse model, treatment with ER stress inhibitors decreased interstitial fibrosis and collagen deposition in the ovary, which was accompanied by a reduction in TGF-β1 expression in granulosa cells. This evidence concerns the gene TGFB1 and polycystic ovary syndrome.